Coinfection with HTLV-I and HIV: Increase in HTLV-I-related outcomes but not accelerated HIV disease progression?

AIDS Patient Care and STDs

Volumn 12, Issue 8, 1998, Pages 619-623

  Harrison, Lee H ^a   Schechter, Mauro ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA; NONHUMAN; PREVALENCE; REVIEW; SPINAL CORD DISEASE; T CELL LEUKEMIA; VIRUS INFECTION;

EID: 0031686065     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1998.12.619     Document Type: Review

References (48)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982;79:2031-2035.
3. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells. Ann Neurol 1987;21: 117-122.
4. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-573.
5. Rosenblatt JD, Golde DW, Wachsman W, et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986;315:372-377.
6. Rosenblatt JD, Gasson JC, Glaspy J, et al. Relationship between human T-cell leukemia virus-II and atypical hairy cell leukemia: A serologic study of hairy cell leukemia patients. Leukemia 1987;1:397-401.
7. Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 1991;163:435-440.
8. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
9. Murphy EL, Hanchard B, Figueroa JP, et al. Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989;43:250-253.
10. Manns A, Blattner WA. The epidemiology of the human T-cell lymphotrophic virus type I and type II: Etiologic role in human disease. Transfusion 1991;31:67-75.
11. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326:375-380.
12. Bessinger R, Beilke M, Kissinger P, Jarrott C, Tabak OF. Retroviral coinfections at a New Orleans HIV outpatient clinic. J AIDS 1997;14:67-71.
13. Schechter M, Harrison LH, Halsey NA, et al. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil: impact on markers of HIV disease progression. JAMA 1994;271:353-357.
14. Moreira ED, Ribeiro TT, Swanson P, et al: Seroepidemiology of human T-cell lymphotropic virus type I/II in Northeastern Brazil. J AIDS 1993;6:959-963.
15. Desormeaux J, Halsey N, Coberly J, et al. Absence of an association between HTLV-I, tuberculosis, and PPD size in HIV-1 positive and HIV-1 negative adults. Seventh International Conference on AIDS, Florence, 1991, abstract MC 3243, p. 358.
16. Quinn TC, Zacarias FR, St. John RK. AIDS in the Americas: An emerging public health crisis. N Engl J Med 1989;320:1005-1007.
17. Pagliuca A, Mufti GJ. Co-infection with HTLV-I/II and HIV-I [Letter]. Lancet 1990;336:383.
18. + (suppressor) T-cell clones transformed by HTLV-I. Proc Natl Acad Sci USA 1986;83:4297-4301.
19. Ruben SM, Rosen CA. Suppression of signals required for activation of transcription factor NF-κB in cells constitutively expressing the HTLV-I tax protein. New Biol 1990;2:894-902.
20. 1 protein. New Biol 1990;2:1034-1043.
21. Böhnlein E, Siekevitz M, Ballard DW, et al. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type 1 tax gene product involves the action of inducible cellular proteins. J Virol 1989;63:1578-1586.
22. Page JB, Lai S, Chitwood DD, Klimas NG, Smith PC, Fletcher MA. HTLV-I/II positivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet 1990;335:1439-1441.
23. Bartholomew C, Blattner WA, Cleghorn F. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet 1987;2:1469.
24. Cleghorn FR, Blattner WA. Does human T cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome [Editorial]? Arch Intern Med 1992;152:1372-1373.
25. Weiss SH. Mortality in the New Jersey IVDA cohort study; roles of HIV, HTLV-II, age, gender and entry symptoms. 1992 Annual Meeting sponsored by the Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, August 8-15, 1992, abstract 1-8.
26. Weiss SH, Altman R, French J, et al. HTLV-I/II co-infection is significantly associated with risk for progression to AIDS among HIV+ intravenous drug abusers. Fifth International Conference on AIDS, Montreal, 1989, abstract Th.A.O.23.
27. Hershow RC, Galai N, Fukuda K, et al. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis 1996;174:309-317.
28. Harrison LH, Quinn TC, Schechter M. Human T-cell lymphotropic virus type I does not increase HIV viral load in vivo. J Infect Dis 1997;175:438-440.
29. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579.
30. Mellors J, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272: 1167-1170.
31. Berger JR, Raffanti S, Svenningsson A, McCarthy M, Snodgrass S, Resnick L. The role of HTLV in HIV-1 neurologic disease. Neurology 1994;41:197-202.
32. Harrison LH, Vaz B, Taveira DM, et al. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology 1997;48: 13-18.
33. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-785.
34. Beilke MA, Japa S, Vinson DG. HTLV-I/II mRNA and antigen expression is increased in HIV and HTLV-I/II dual infection. 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22-26, 1997.
35. Woods TC, Graber JM, Hershow RC, Khabbaz RF, Kaplan JE, Heneine W. Investigation of proviral load in individuals infected with human T-lymphotropic virus type II. AIDS Res Hum Retrovir 1995;11: 1235-1239.
36. Fantry L, Dodging E, Auwaerter PG, Lederman HM. Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. Clin Infect Dis 1995;21:1466-1468.
37. + lymphocyte counts in subjects coinfected with HTLV-I and HIV-1. J AIDS 1997;15: 308-311.
38. Dorrucci M, Pezzotti P, Phillips AN, Lepri AS, Rezza G. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J Infect Dis 1995;172:1503-1508.
39. Solomon RE, VanRaden M, Kaslow RA, et al. Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Am J Pub Health 1990;80:1475-1478.
40. Schinaia N, Ghirardini Am, Mazzucconi MG, Tagariello G, Morfini M, Chiarotti F. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. Thromb Haemost 1994;72:33-38.
41. Webster A, Lee CA, Cook DG, Grundy JE, Emergy VC, Kernoff PB, Griffiths PD. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet 1989;2:63-66.
42. Rabkin CS, Hatzakis A, Griffiths PD, et al. Cytomegalovirus infection and risk of AIDs in human immunodeficiency virus-infected hemophilia patients. J Infect Dis 1993;168:1260-1263.
43. Detels R, Leach CT, Hennessey K, et al. Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis 1994;169:766-768.
44. Mole L, Ripich S, Margolis, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176: 766-770.
45. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334: 1222-1230.
46. Donovan RM, Bush CE, Markowitz NP, Baxa DM, Saravolatz LD. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996;174:401-403.
47. Youle MS, Gazzard BG, Johnson MA, et al. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: A double-blind, placebo-controlled study. AIDS 1994;8: 641-649.
48. Cooper DA, Pehrson PO, Pedersen C, et al. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: A double-blind randomized trial. AIDS 1993;7:197-207.